BioSpace2d
Gilead Continues Diversification Drive With Potential $1.7B Inflammation Pact With LEO
Gilead’s investment will let it assess the therapeutic potential of targeting STAT6, a transcription factor involved in IL-4 ...
Business Wire4d
Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases
Gilead Sciences, Inc. (Nasdaq: GILD) and LEO Pharma today announced a strategic partnership to accelerate the development and ...
FierceBiotech7d
Galapagos splits in 2, laying off 40% of staff, shrinking pipeline and ending Gilead partnership
The split-up of Galapagos is only the latest shake-up in the company in recent years. Other major events have included the ...
‘The Handmaid's Tale': First Look At Sixth & Final Season
Offred (Moss), one of the few fertile women known as Handmaids in the oppressive Republic of Gilead, struggles to survive as ...
Gilead in pact for anti-inflammatory drugs in a deal worth up to $1.7B
Gilead Sciences (GILD) partners with LEO Pharma in a $1.7B agreement to develop anti-inflammatory drugs. Read more here.
Reuters29d
New HIV prevention drug could reach poorest countries by 2025, says health official
The ambition is to start deliveries of Gilead Sciences’ (GILD.O), opens new tab lenacapavir on that timeline, said Hui Yang, head of supply operations at the Global Fund to Fight AIDS ...
The Handmaid's Tale shares first look at season 6 as it announces return after two-year hiatus
A batch of production stills have been unveiled, painting a grim picture of the Republic of Gilead. Featured in the newly ...